0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 101-120 of 111 Articles
Original Investigation |  FREE
Michael Shannon, MD, MPH
Arch Intern Med. 1999;159(9):989-994. doi:10.1001/archinte.159.9.989.

Original Investigation |  FREE
Leslie V. Boyer, MD; Steven A. Seifert, MD; Richard F. Clark, MD; et al.
Arch Intern Med. 1999;159(7):706-710. doi:10.1001/archinte.159.7.706.

Original Investigation |  FREE
Fina Cañas; Milenko J. Tanasijevic, MD; Nell Ma'luf; et al.
Arch Intern Med. 1999;159(4):363-368. doi:10.1001/archinte.159.4.363.

Original Investigation |  FREE
Kristin M. Williamson, PharmD, BCPS; Kimberly A. Thrasher, PharmD, BCPS; Kathey B. Fulton, PharmD; et al.
Arch Intern Med. 1998;158(22):2444-2449. doi:10.1001/archinte.158.22.2444.

Commentary | 
James S. Goodwin, MD; Michael R. Tangum, MD
Arch Intern Med. 1998;158(20):2187-2191. doi:10.1001/archinte.158.20.2187.

Original Investigation |  FREE
Jimmy Dy Chua, MD; William R. Friedenberg, MD
Arch Intern Med. 1998;158(17):1929-1932. doi:10.1001/archinte.158.17.1929.

Original Investigation |  FREE
Mark H. Eckman, MD; Rodney H. Falk, MD; Stephen G. Pauker, MD
Arch Intern Med. 1998;158(15):1669-1677. doi:10.1001/archinte.158.15.1669.

Clinical Observation | 
Arthur Leibovitz, MD; Tamara Bilchinsky, MD; Israel Gil, MD; et al.
Arch Intern Med. 1998;158(10):1152-1153. doi:10.1001/archinte.158.10.1152.

Clinical Observation | 
Cristóbal Leonel Díaz-Sánchez, MD; Alberto Lifshitz-Guinzberg, MD; Gregorio Ignacio-Ibarra, MD; et al.
Arch Intern Med. 1998;158(8):925-927. doi:10.1001/archinte.158.8.925.

Clinical Observation | 
Barry Kirschbaum, MD
Arch Intern Med. 1998;158(4):405-408. doi:10.1001/archinte.158.4.405.

Review Article |  FREE
Peter R. Kowey, MD
Arch Intern Med. 1998;158(4):325-332. doi:10.1001/archinte.158.4.325.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncology
Invited Commentary  | 
Biomarkers of Fluorouracil Toxicity Insight From the PETACC-8 Trial
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.